跳到正文
Prof Tom John· @TommyJohn00 · X·· 1 天前评分45

#LCSM

正文 · 原文

@LeXiuning giving excellent discussion on ctDNA dynamics. Notable that those without ctDNA at baseline derive limited benefit from addition of chemo. But questions about whether persistence warrants addition of chemo versus treating all ctDNA+ #LCSM #ESMO26

7 浏览 · 0 赞 · 0 转发 · 0 回复

来源:Prof Tom John · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org